DR. GREGORY J OAKHILL M.D. NPI 1356312466

NPI Details

DR. Gregory J Oakhill, M.D. is a hematology and oncology internal medicine in Fayetteville, AR with 32 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Gregory J Oakhill, M.D. NPI is 1356312466. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Graduation Year:1994

The provider's business location address is:

3232 N NORTHHILLS BLVD
FAYETTEVILLE, AR
ZIP 72703-005
Phone: (479) 587-1700
Fax: (479) 587-1366

The NPI 1356312466 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, durvalumab, 10 mg (HCPCS:J9173)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Magnesium level (HCPCS:83735)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Phosphate level (HCPCS:84100)
• Uric acid level, blood (HCPCS:84550)
• Bilirubin level, direct (HCPCS:82248)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, pemetrexed, not otherwise specified, 10 mg (HCPCS:J9305)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, octreotide, depot form for intramuscular injection, 1 mg (HCPCS:J2353)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Vitamin d-3 level (HCPCS:82306)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Ct scan of chest with contrast (HCPCS:71260)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg (HCPCS:Q5108)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Mri scan of brain before and after contrast (HCPCS:70553)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Ct scan of chest without contrast (HCPCS:71250)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Unclassified drugs (HCPCS:J3490)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Blood test, clotting time (HCPCS:85610)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Ct scan of soft tissue of neck without contrast (HCPCS:70490)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• X-ray of chest, 2 views (HCPCS:71046)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Blood creatinine level (HCPCS:82565)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Ct scan of head or brain before and after contrast (HCPCS:70470)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Drawing of blood for a medical problem (HCPCS:99195)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Injection of drug or substance into vein (HCPCS:96374)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Mri scan of abdomen before and after contrast (HCPCS:74183)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Ct scan of blood vessels of chest with contrast (HCPCS:71275)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Ct scan head or brain without contrast (HCPCS:70450)
• Injection, meperidine hydrochloride, per 100 mg (HCPCS:J2175)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
• Limited ultrasound scan of abdomen (HCPCS:76705)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Collection of blood sample from implanted device (HCPCS:36591)
• Transitional care management services for problem of high complexity (HCPCS:99496)

The enumeration date for this NPI number is 1/27/2006 and was last updated on 3/30/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.